Results 61 to 70 of about 223,805 (190)

Factors for Success and Failure of Allergen Immunotherapy (AIT) Trial Design in the Light of Evidence‐Based Medicine: Current Aspects 2026

Allergy, EarlyView.
ABSTRACT Allergen immunotherapy (AIT) has been acknowledged as the only disease‐modifying treatment for respiratory diseases since its introduction in 1911. Although the efficacy and safety have convincingly been established in numerous randomized clinical trials (RCTs), the AIT study results may vary substantially.
Roy Gerth van Wijk, Vera Mahler, Melanie Albrecht, Danilo di Bona, Benjamin Hofner, Jasper Kappen, Susanne Kaul, Graham Roberts, Mohamed H. Shamji, Stefan Vieths, Oliver Pfaar   +10 more
wiley   +1 more source

A Case of Eosinophilic Pneumonia in a Tobacco Harvester

Allergology International, 2011
Background: Eosinophilic pneumonia comprises a group of lung diseases in which eosinophils appear in increased numbers in the lungs. The distinct etiology of eosinophilic pneumonia is unknown, although the previous case series have indicated a ...
Daisuke Yoshioka, Hiroshi Ishii, Yutaka Hatano, Kenji Umeki, Noriho Sakamoto, Ryo Shirai, Sakuhei Fujiwara, Jun-ichi Kadota   +7 more
doaj   +1 more source

A pediatric case of fascioliasis with eosinophilic pneumonia [PDF]

, 2016
Fasciolia spp. are common trematode infestations worldwide. Fasciolia spp. may lead to hepatic diseases in the acute phase and may cause biliary diseases in the chronic phase. In addition, Fasciolia spp.
Abdulsamet Batur, Demiroren, Kaan, Ayşegül Taylan-Özkan, Yunus Emre Beyhan, Bayhan, Gulsum Iclal, Taylan-Ozkan, Aysegul, Gülsüm İclal Bayhan, Beyhan, Yunus Emre, Taylan Özkan, Hikmet Ayşegül, Kaan Demirören, Batur, Abdulsamet   +10 more
core   +1 more source

Asthma Remission From Childhood to Young Adulthood–A Population‐Based Cohort Study

Allergy, EarlyView.
Among 257 participants with asthma at age 8 years, 39% achieved symptom‐based remission by age 24, 29% achieved clinical remission, and 18% achieved complete remission. Male sex increased the likelihood of symptom‐based remission, while food sensitization and overweight/obesity decreased the likelihood.
Lina Broström, Anna Bergström, Anne‐Sophie Merritt, Maria Ödling, Erik Melén, Inger Kull, Sandra Ekström   +6 more
wiley   +1 more source

CT patterns and differential criteria for acute eosinophilic pneumonia and COVID‐19 pneumonia

Clinical Case Reports, 2021
Difficulties encountered in diagnosing and treating COVID‐19 pneumonia and acute eosinophilic pneumonia during the pandemic from 2019 to 2021 led to the identification and study of the differential features of the two conditions.
Aliya Kadyrova, Irina Antipina, Indira Kyrbasheva, Iliar Baudinov, Begaim Kulbaeva, Uuljan Aitieva, Cholponbek Zhunushaliev, Yethindra Vityala, Tugolbai Tagaev   +8 more
doaj   +1 more source

IgE‐Binding Bacterial Components Not Yet Documented in the Allergen Databases and Their Allergenic Mechanisms: An EAACI Position Paper

Allergy, EarlyView.
ABSTRACT Among bacteria that are associated with the development and/or exacerbation of allergic/atopic diseases, several have been described to produce IgE‐binding components. However, only one bacterial protein, Bac s 1, is currently listed in the official database of the World Health Organization/International Union of Immunological Societies (WHO ...
Uta Jappe, Marua Abu Risha, Ioana Agache, Claus Bachert, Barbara Bröker, Riccardo Castagnoli, Gabriele Gadermaier, Richard E. Goodman, Amir Guemari, Christiane Hilger, Alain Jacquet, Sabine Kespohl, Ludger Klimek, Annette Kuehn, Jonas Lidholm, Vera Mahler, Markus Ollert, Thomas A. Platts‐Mills, Monika Raulf, Peter Schmid‐Grendelmeier, Frieder Schmiedeke, Marianne van Hage, Joana Vitte, Josefina Zakzuk, Anna Pomés   +24 more
wiley   +1 more source

Chronic eosinophilic pneumonia: clinical perspectives

, 2019
Matthew Crowe,1 Drew Robinson,2 Malvika Sagar,3 Li Chen,4 Shekhar Ghamande1 1Department of Medicine, Division of Pulmonary and Critical Care, Baylor Scott and White Medical Center, Temple, TX, USA; 2Department of Medicine, Baylor Scott and White Medical
Sagar M, Crowe M, Chen L, Ghamande S, Robinson D   +4 more
core  

Understanding the Type 2 Immunity: An Evolving View Beyond Allergic Diseases

Allergy, EarlyView.
ABSTRACT Type 2 (T2) immunity is classically associated with defense against helminths and environmental threats, from a physiological perspective, and with allergies and eosinophilic inflammatory diseases, in a pathological sense. However, growing evidence reveals that T2 pathways also support other essential homeostatic functions, including tissue ...
Rodrigo Jiménez‐Saiz, Salvador Iborra, Carlos Blanco, Ruperto González‐Pérez, Emilio Nuñez‐Borque, Can Zeyneloglu, Huseyn Babayev, Ozlem Göksel, Tuncay Göksel, Musa Khaitov, Dmitry Kudlay, Yadong Gao, Mustafa Sevim, Marie‐Charlotte Brüggen, Oral Alpan, Ming Wang, Luo Zhang, María J. Torres, Mohamed Shamji, Mübeccel Akdis, Kari C. Nadeau, Ismail Ogulur, Cezmi A. Akdis   +22 more
wiley   +1 more source

Chronic eosinophilic pneumonia [PDF]

, 2002
Pneumonia eosinofílica crônica é uma entidade clínica rara que se caracteriza por infiltração alveolar e intersticial eosinofílica, de causa desconhecida.
Perin, Chiristiano, Rubin, Adalberto Sperb, Zille, Alessandra Isabel, Geyer, Geraldo Resin, Hetzel, Jorge Lima   +4 more
core   +1 more source

Acute Eosinophilic Pneumonia with Respiratory Failure Induced by Synthetic Cannabinoid Inhalation

Balkan Medical Journal, 2016
Background: In recent days, synthetic cannabinoid derivatives have become life threatening for young people. Here, we want to share a case of acute eosinophilic pneumonia triggered by inhalation of synthetic cannabinoid, new side effects of which are ...
Nesrin Öcal, Deniz Doğan, Ali Fuat Çiçek, Orhan Yücel, Ergun Tozkoparan   +4 more
doaj   +1 more source